Log In
BCIQ
Print this Print this
 

Biosimilar trastuzumab (ISU103)

  Manage Alerts
Collapse Summary General Information
Company Isu Abxis Co. Ltd.
DescriptionBiosimilar of herceptin
Molecular Target
Mechanism of ActionAntibody; Biosimilar
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat breast cancer
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today